Swiss CTI Approved Phase 3 CTI Coaching

---

August 8, 2025

In August, the SunRegen founder team presented their SBC003 project in the CTI coaching acceptance meeting. The jury acknowledged the high potential value in the market for treatments of neurodegenerative disorders. Swiss CTI decided to continue to support SunRegen and to offer professional coaching, executed by Dr. Andreas J. Schulze.

The Swiss CTI Phase 3 coaching program is designed to help innovative startups in life sciences develop their projects and bring them closer to market. Additionally, the program provides expert guidance, mentorship, and networking opportunities that are critical for advancing early-stage therapeutics.

SunRegen’s participation in the Swiss CTI Phase 3 coaching reflects the company’s strong potential in the field of neurodegenerative disorder treatments. Furthermore, this support allows the team to refine their project strategy, optimize research processes, and prepare for potential clinical development.

The CTI coaching program is executed by experienced professionals such as Dr. Andreas J. Schulze, offering personalized advice to accelerate innovation. In addition, the program connects SunRegen with other biotech innovators, investors, and research partners, fostering collaboration and knowledge sharing.

For more information on CTI coaching programs and Swiss startup support, visit CTI Switzerland or explore Swiss innovation funding opportunities. You can also view SunRegen’s research initiatives to see ongoing projects and advancements in neurodegenerative treatments.

As a result, completing the Swiss CTI Phase 3 coaching will help SunRegen strengthen its research capabilities, expand collaborations, and accelerate the development of innovative therapies for neurodegenerative disorders.